BenefitsPRO: Employee Benefits News, Trends & Sales Tips

Hims & Hers retreats on cheap Wegovy pill amid legal firestorm

By David Ostrowsky

Novo Nordisk believes that by marketing such untested medicines, Hims & Hers is exposing patients to drugs that may contain dangerous impurities or incorrect amounts of active ingredients, resulting in life-jeopardizing immune reactions.

Read Story

Cost-Containment

The Rise of Oral GLP-1s

Broker Regulation

Why COBRA and enrollment should live under one roof

Recommended Just For You

Commentary Stories

March 13, 2026

GLP-1 coverage without personal support is a recipe for wasted wellness dollars

Stepping away from an app-based program and leaning into a more personalized model can allow employers to recalibrate their wellness strategies and finally achieve measurable outcomes for their workforce.

Read

March 11, 2026

How women are redefining the high-stakes benefits market

Ensuring diverse perspectives are part of change will help agencies build solutions that better reflect the needs of the businesses and employees they serve.

Read

March 09, 2026

Fine-tune, don't overhaul: 401(k) investors maintain calm confidence

Use this calm period to strengthen communications around diversification, highlight the value of staying invested and remind participants why their measured approach works.

Read

March 04, 2026

Adaptability quotient is the new priority for HR leaders, advisors in 2026

Adaptability quotient can be developed over time, but it is more than just a standalone skill; it's a culture.

Read

March 03, 2026

Helping employees avoid FSA forfeitures with the latest spending trends

HR teams are a critical element to empowering individuals and families to make the most of their employer-sponsored benefits, while supporting their financial health now, and in the future.

Read

February 27, 2026

From diagnosis to survivorship: Building a compassionate and effective cancer benefit strategy

But employers aren't powerless. They have meaningful levers that shape how employees access cancer expertise, navigate decisions, and receive timely, evidence-based care.

Read

February 26, 2026

Retirement plan amendment deadlines extended past 2026 for certain provisions

When the IRS issued the 2025 Required Amendments List at the end of last year, however, it further delayed the amendment deadline for certain limited changes until after 2026.

Read

‹ ‹ PREV 3 4 5 ... 239 › NEXT ›

Commentary

Top Commentary Stories

Hims & Hers retreats on cheap Wegovy pill amid legal firestorm

The Rise of Oral GLP-1s

Why COBRA and enrollment should live under one roof

Recommended Just For You

Commentary Stories

GLP-1 coverage without personal support is a recipe for wasted wellness dollars

How women are redefining the high-stakes benefits market

Fine-tune, don't overhaul: 401(k) investors maintain calm confidence

Adaptability quotient is the new priority for HR leaders, advisors in 2026

Helping employees avoid FSA forfeitures with the latest spending trends

From diagnosis to survivorship: Building a compassionate and effective cancer benefit strategy

Retirement plan amendment deadlines extended past 2026 for certain provisions